Intellia Therapeutics
NTLA
NTLA
148 hedge funds and large institutions have $582M invested in Intellia Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+7
Holders Change %
+4.96%
% of All Funds
3.21%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
26
Increased
49
Reduced
29
Closed
19
Calls
$3.31M
Puts
$2.41M
Net Calls
+$909K
Net Calls Change
+$132K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$20.1M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$18.2M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$17.9M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.2M |
| 5 |
BlackRock
New York
|
+$5.35M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9.87M |
| 2 |
State Street
Boston,
Massachusetts
|
-$9.16M |
| 3 |
Morgan Stanley
New York
|
-$4.57M |
| 4 |
Citigroup
New York
|
-$4.08M |
| 5 |
Renaissance Technologies
New York
|
-$3.11M |
